Helena Cornellà

3.3k total citations
11 papers, 1.3k citations indexed

About

Helena Cornellà is a scholar working on Molecular Biology, Hepatology and Cancer Research. According to data from OpenAlex, Helena Cornellà has authored 11 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 5 papers in Hepatology and 5 papers in Cancer Research. Recurrent topics in Helena Cornellà's work include Hepatocellular Carcinoma Treatment and Prognosis (5 papers), MicroRNA in disease regulation (3 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (2 papers). Helena Cornellà is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (5 papers), MicroRNA in disease regulation (3 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (2 papers). Helena Cornellà collaborates with scholars based in Spain, United States and Malaysia. Helena Cornellà's co-authors include Augusto Villanueva, Agrin Moeini, Josep M. Llovet, Yujin Hoshida, Clara Alsinet, Carlo Battiston, Vincenzo Mazzaferro, Daniela Sia, Tina Catela Ivković and Manel Solé and has published in prestigious journals such as Gastroenterology, Hepatology and Gut.

In The Last Decade

Helena Cornellà

11 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Helena Cornellà Spain 9 732 574 480 250 250 11 1.3k
Laia Cabellos Spain 9 721 1.0× 514 0.9× 464 1.0× 164 0.7× 235 0.9× 19 1.3k
Sandrine Boyault France 14 1.0k 1.4× 503 0.9× 503 1.0× 260 1.0× 351 1.4× 20 1.7k
Giorgia Marisi Italy 23 603 0.8× 616 1.1× 423 0.9× 233 0.9× 478 1.9× 71 1.4k
Cheol-Keun Park South Korea 23 682 0.9× 441 0.8× 293 0.6× 200 0.8× 371 1.5× 48 1.3k
Renan Jin China 17 703 1.0× 463 0.8× 258 0.5× 195 0.8× 274 1.1× 34 1.2k
Amanda J. Craig United States 14 709 1.0× 586 1.0× 346 0.7× 334 1.3× 390 1.6× 31 1.4k
Le‐Qun Li China 20 685 0.9× 598 1.0× 312 0.7× 197 0.8× 542 2.2× 63 1.5k
Guangzhi Zhu China 20 700 1.0× 564 1.0× 168 0.3× 379 1.5× 284 1.1× 95 1.3k
Ying‐Hao Shen China 23 571 0.8× 418 0.7× 499 1.0× 247 1.0× 413 1.7× 75 1.5k
Pál Kaposi-Novák United States 12 820 1.1× 456 0.8× 764 1.6× 147 0.6× 384 1.5× 15 1.6k

Countries citing papers authored by Helena Cornellà

Since Specialization
Citations

This map shows the geographic impact of Helena Cornellà's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Helena Cornellà with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Helena Cornellà more than expected).

Fields of papers citing papers by Helena Cornellà

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Helena Cornellà. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Helena Cornellà. The network helps show where Helena Cornellà may publish in the future.

Co-authorship network of co-authors of Helena Cornellà

This figure shows the co-authorship network connecting the top 25 collaborators of Helena Cornellà. A scholar is included among the top collaborators of Helena Cornellà based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Helena Cornellà. Helena Cornellà is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Ivković, Tina Catela, Helena Cornellà, Gjendine Voss, et al.. (2023). Functional In Vivo Screening Identifies microRNAs Regulating Metastatic Dissemination of Prostate Cancer Cells to Bone Marrow. Cancers. 15(15). 3892–3892. 2 indexed citations
2.
Conboy, Caitlin B., Barbara R. Tschida, Gabriel Kaufmann, et al.. (2019). R‐spondin 2 Drives Liver Tumor Development in a Yes‐Associated Protein‐Dependent Manner. Hepatology Communications. 3(11). 1496–1509. 20 indexed citations
3.
Ivković, Tina Catela, Gjendine Voss, Helena Cornellà, & Yvonne Ceder. (2017). microRNAs as cancer therapeutics: A step closer to clinical application. Cancer Letters. 407. 113–122. 112 indexed citations
4.
Torrecilla, Sara, Daniela Sia, Andrew Harrington, et al.. (2017). Trunk mutational events present minimal intra- and inter-tumoral heterogeneity in hepatocellular carcinoma. Journal of Hepatology. 67(6). 1222–1231. 118 indexed citations
5.
Tovar, Victoria, Helena Cornellà, Agrin Moeini, et al.. (2015). Tumour initiating cells and IGF/FGF signalling contribute to sorafenib resistance in hepatocellular carcinoma. Gut. 66(3). 530–540. 160 indexed citations
6.
Villanueva, Augusto, Anna Portela, Sergi Sayols, et al.. (2015). DNA methylation‐based prognosis and epidrivers in hepatocellular carcinoma. Hepatology. 61(6). 1945–1956. 315 indexed citations
7.
Moeini, Agrin, Helena Cornellà, & Augusto Villanueva. (2012). Emerging Signaling Pathways in Hepatocellular Carcinoma. Liver Cancer. 1(2). 83–93. 160 indexed citations
8.
Cornellà, Helena, et al.. (2012). 314 INDUCTION OF HEPATOCELLULAR CARCINOMA BY IN VIVO GENE TARGETING. Journal of Hepatology. 56. S128–S128. 7 indexed citations
9.
Villanueva, Augusto, Yujin Hoshida, Carlo Battiston, et al.. (2011). Combining Clinical, Pathology, and Gene Expression Data to Predict Recurrence of Hepatocellular Carcinoma. Gastroenterology. 140(5). 1501–1512.e2. 312 indexed citations
10.
Cornellà, Helena, Clara Alsinet, & Augusto Villanueva. (2011). Molecular Pathogenesis of Hepatocellular Carcinoma. Alcoholism Clinical and Experimental Research. 35(5). 821–825. 43 indexed citations
11.
Villanueva, Augusto, Yujin Hoshida, Sara Toffanin, et al.. (2010). New Strategies in Hepatocellular Carcinoma: Genomic Prognostic Markers. Clinical Cancer Research. 16(19). 4688–4694. 99 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Laia Cabellos Breakdown of academic impact, for papers by Sandrine Boyault Breakdown of academic impact, for papers by Giorgia Marisi Breakdown of academic impact, for papers by Cheol-Keun Park Breakdown of academic impact, for papers by Renan Jin Breakdown of academic impact, for papers by Amanda J. Craig Breakdown of academic impact, for papers by Le‐Qun Li Breakdown of academic impact, for papers by Guangzhi Zhu Breakdown of academic impact, for papers by Ying‐Hao Shen Breakdown of academic impact, for papers by Pál Kaposi-Novák
Rankless by CCL
2026